View in EDS

1503TiPCheckMate 592: A phase II exploratory study of biomarkers associated with the efficacy of first-line nivolumab (nivo) plus ipilimumab (ipi) in patients (pts) with stage IV or recurrent NSCLC.

Saved in:
Bibliographic Details
Title: 1503TiPCheckMate 592: A phase II exploratory study of biomarkers associated with the efficacy of first-line nivolumab (nivo) plus ipilimumab (ipi) in patients (pts) with stage IV or recurrent NSCLC.
Authors: Gettinger, S1 (AUTHOR), Beck, T2 (AUTHOR), Yang, X3 (AUTHOR), Telivala, B4 (AUTHOR), Morgensztern, D5 (AUTHOR), Velcheti, V6 (AUTHOR), Ramalingam, S S7 (AUTHOR), Schalper, K8 (AUTHOR), Dajee, M9 (AUTHOR), Ranck, A10 (AUTHOR)
Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 133285559
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 1503TiPCheckMate 592: A phase II exploratory study of biomarkers associated with the efficacy of first-line nivolumab (nivo) plus ipilimumab (ipi) in patients (pts) with stage IV or recurrent NSCLC.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Gettinger%2C+S%22">Gettinger, S</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Beck%2C+T%22">Beck, T</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+X%22">Yang, X</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Telivala%2C+B%22">Telivala, B</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Morgensztern%2C+D%22">Morgensztern, D</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Velcheti%2C+V%22">Velcheti, V</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ramalingam%2C+S+S%22">Ramalingam, S S</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schalper%2C+K%22">Schalper, K</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dajee%2C+M%22">Dajee, M</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ranck%2C+A%22">Ranck, A</searchLink><relatesTo>10</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=133285559
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdy292.124
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: N.PAG
    Titles:
      – TitleFull: 1503TiPCheckMate 592: A phase II exploratory study of biomarkers associated with the efficacy of first-line nivolumab (nivo) plus ipilimumab (ipi) in patients (pts) with stage IV or recurrent NSCLC.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gettinger, S
      – PersonEntity:
          Name:
            NameFull: Beck, T
      – PersonEntity:
          Name:
            NameFull: Yang, X
      – PersonEntity:
          Name:
            NameFull: Telivala, B
      – PersonEntity:
          Name:
            NameFull: Morgensztern, D
      – PersonEntity:
          Name:
            NameFull: Velcheti, V
      – PersonEntity:
          Name:
            NameFull: Ramalingam, S S
      – PersonEntity:
          Name:
            NameFull: Schalper, K
      – PersonEntity:
          Name:
            NameFull: Dajee, M
      – PersonEntity:
          Name:
            NameFull: Ranck, A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 10
              Text: 2018 Supplement
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 29
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1